The purchase brings Covidien into the gastroenterology field. Barrx will be operated as a standalone division of Covidien and staffed by current Barrx employees.
The company’s offerings include the Halo system, a radiofrequency ablation device to treat Barrett’s esophagus by using radiofrequency energy to remove a thin layer of tissue off the inner esophageal lining so healthy tissue can grow.
Related Articles on Gastroenterology:
Study: Laparoscopic Surgery May be Safer Than Open Bariatric Surgery
Median Survival Time for Colon Cancer Increases 17-Fold
IBD Patients Face Higher Risk of Skin Cancer
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
